A new staphylococcal anti-inflammatory protein that antagonizes the formyl peptide receptor-like 1

Journal of Immunology

Volumn 177, Issue 11, 2006, Pages 8017-8026

  Prat, Cristina ^a,b   Bestebroer, Jovanka ^a   De Haas, Carla J C ^a   Van Strijp, Jos A G ^a   Van Kessel, Kok P M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BACTERIAL PROTEIN; CALCIUM; CHEMOTAXIS INHIBITORY PROTEIN; COMPLEMENT COMPONENT C5A RECEPTOR; FLUORESCENT DYE; FORMYL PEPTIDE RECEPTOR 1; FORMYLMETHIONYLLEUCYLPHENYLALANINE; FORMYLPEPTIDE RECEPTOR; LIGAND; LYSINE; METHIONINE; PRION PROTEIN[106-126]; PROTEIN MMK 1; RECEPTOR BLOCKING AGENT; STAPHYLOCOCCAL ANTIINFLAMMATORY PROTEIN; SYNTHETIC PEPTIDE; TRYPTOPHAN; TYROSINE; UNCLASSIFIED DRUG; VALINE;

ALZHEIMER DISEASE; AMYLOIDOSIS; ARTICLE; B LYMPHOCYTE; CALCIUM MOBILIZATION; CELL STRAIN HEK293; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENETIC TRANSFECTION; HOST RESISTANCE; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; NORMAL HUMAN; PHAGOCYTE; PRION DISEASE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 33751565688     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.11.8017     Document Type: Article

References (57)

1. Lowy, F. D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339: 520-532.
2. Foster, T. J. 2005. Immune evasion by staphylococci. Nat. Rev. Microbiol. 3: 948-958.
3. Charo, I. F., and R. M. Ransohoff. 2006. The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354: 610-621.
4. Ji, T. H., M. Grossmann, and I. Ji. 1998. G protein-coupled receptors. I. Diversity of receptor-ligand interactions. J. Biol. Chem. 273: 17299-17302.
5. de Haas, C. J., K. E. Veldkamp, A. Peschel, F. Weerkamp, W. J. Van Wamel, E. C. Heezius, M. J. Poppelier, K. P. van Kessel, and J. A. van Strijp. 2004. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J. Exp. Med. 199: 687-695.
6. Postma, B., M. J. Poppelier, J. C. van Galen, E. R. Prossnitz, J. A. van Strijp, C. J. de Haas, and K. P. van Kessel. 2004. Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor. J. Immunol. 172: 6994-7001.
7. Lacy, M., J. Jones, S. R. Whittemore, D. L. Haviland, R. A. Wetsel, and S. R. Barnum. 1995. Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia. J. Neuroimmunol. 61: 71-78.
8. McCoy, R., D. L. Haviland, E. P. Molmenti, T. Ziambaras, R. A. Wetsel, and D. H. Perlmutter. 1995. N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation. J. Exp. Med. 182: 207-217.
9. Sozzani, S., F. Sallusto, W. Luini, D. Zhou, L. Piemonti, P. Allavena, J. Van Damme, S. Valitutti, A. Lanzavecchia, and A. Mantovani. 1995. Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J. Immunol. 155: 3292-3295.
10. Christophe, T., A. Karlsson, C. Dugave, M. J. Rabiet, F. Boulay, and C. Dahlgren. 2001. The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2. J. Biol. Chem. 276: 21585-21593.
11. Le, Y., P. M. Murphy, and I. M. Wang. 2002. Formyl-peptide receptors revisited. Trends Immunol. 23: 541-548.
12. Yang, D., Q. Chen, Y. Le, J. M. Wang, and J. J. Oppenheim. 2001. Differential regulation of formyl peptide receptor-like 1 expression during the differentiation of monocytes to dendritic cells and macrophages. J. Immunol. 166: 4092-4098.
13. Le, Y., J. J. Oppenheim, and J. M. Wang. 2001. Pleiotropic roles of formyl peptide receptors. Cytokine Growth Factor Rev. 12: 91-105.
14. Fu, H., J. Karlsson, J. Bylund, C. Movitz, A. Karlsson, and C. Dahlgren. 2006. Ligand recognition and activation of formyl peptide receptors in neutrophils. J. Leukocyte Biol. 79: 247-256.
15. Su, S. B., W. Gong, J. L. Gao, W. Shen, P. M. Murphy, J. J. Oppenheim, and J. M. Wang. 1999. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189: 395-402.
16. Le, Y., W. Gong, H. L. Tiffany, A. Tumanov, S. Nedospasov, W. Shen, N. M. Dunlop, J. L. Gao, P. M. Murphy, J. J. Oppenheim, and J. M. Wang. 2001. Amyloid β42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1. J. Neurosci. 21: RC123.
17. Le, Y., H. Yazawa, W. Gong, Z. Yu, V. J. Ferrans, P. M. Murphy, and J. M. Wang. 2001. The neurotoxic prion peptide fragment PrP(106-126) is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1. J. Immunol. 166: 1448-1451.
18. Cui, Y., Y. Le, H. Yazawa, W. Gong, and J. M. Wang. 2002. Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease. J. Leukocyte Biol. 72: 628-635.
19. Hu, J. Y., Y. Le, W. Gong, N. M. Dunlop, J. L. Gao, P. M. Murphy, and J. M. Wang. 2001. Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1. J. Leukocyte Biol. 70: 155-161.
20. Le, Y., W. Gong, B. Li, N. M. Dunlop, W. Shen, S. B. Su, R. D. Ye, and J. M. Wang. 1999. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. J. Immunol. 163: 6777-6784.
21. Christophe, T., A. Karlsson, M. J. Rabiet, F. Boulay, and C. Dahlgren. 2002. Phagocyte activation by Trp-Lys-Tyr-Met-Val-Met, acting through FPRL1/LXA4R, is not affected by lipoxin A4. Scand. J. Immunol. 56: 470-476.
22. Migeotte, I., E. Riboldi, J. D. Franssen, F. Gregoire, C. Loison, V. Wittamer, M. Detheux, P. Robberecht, S. Costagliola, G. Vassart, et al. 2005. Identification and characterization of an endogenous chemotactic ligand specific for FPRL2. J. Exp. Med 201: 83-93.
23. Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77: 51-59.
24. Postma, B., W. Kleibeuker, M. J. Poppelier, M. Boonstra, K. P. van Kessel, J. A. van Strijp, and C. J. de Haas. 2005. Residues 10-18 within the C5a receptor N terminus compose a binding domain for chemotaxis inhibitory protein of Staphylococcus aureus. J. Biol. Chem. 280: 2020-2027.
25. Veldkamp, K. E., K. P. van Kessel, J. Verhoef, and J. A. van Strijp. 1997. Staphylococcal culture supernates stimulate human phagocytes. Inflammation 21: 541-551.
26. Keller, H. U., A. Fedier, and R. Rohner. 1995. Relationship between light scattering in flow cytometry and changes in shape, volume, and actin polymerization in human polymorphonuclear leukocytes. J. Leukocyte Biol. 58: 519-525.
27. Bae, Y. S., Y. Kim, Y. Kim, J. H. Kim, P. G. Suh, and S. H. Ryu. 1999. Trp-Lys-Tyr-Met-Val-D-Met is a chemoattractant for human phagocytic cells. J. Leukocyte Biol. 66: 915-922.
28. van Kessel, K. P., J. A. van Strijp, and J. Verhoef. 1991. Inactivation of recombinant human tumor necrosis factor-α by proteolytic enzymes released from stimulated human neutrophils. J. Immunol. 147: 3862-3868.
29. McGeer, E. G., and P. L. McGeer. 2003. Inflammatory processes in Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 27: 741-749.
30. Bae, Y. S., H. Y. Lee, E. J. Jo, J. I. Kim, H. K. Kang, R. D. Ye, J. Y. Kwak, and S. H. Ryu. 2004. Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling. J. Immunol. 173: 607-614.
31. Tiffany, H. L., M. C. Lavigne, Y. H. Cui, J. M. Wang, T. L. Leto, J. L. Gao, and P. M. Murphy. 2001. Amyloid-β induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain. J. Biol. Chem. 276: 23645-23652.
32. Diomede, L., S. Sozzani, W. Luini, M. Algeri, L. De Gioia, R. Chiesa, P. M. Lievens, O. Bugiani, G. Forloni, F. Tagliavini, and M. Salmona. 1996. Activation effects of a prion protein fragment [PrP-(106-126)] on human leucocytes. Biochem. J. 320(Pt. 2): 563-570.
33. Fiore, S., J. F. Maddox, H. D. Perez, and C. N. Serhan. 1994. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. J. Exp. Med 180: 253-260.
34. Colgan, S. P., C. N. Serhan, C. A. Parkos, C. Delp-Archer, and J. L. Madara. 1993. Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers. J. Clin. Invest. 92: 75-82.
35. Lee, T. H., C. E. Horton, U. Kyan-Aung, D. Haskard, A. E. Crea, and B. W. Spur. 1989. Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-L-methionyl-L-leucyl-L- phenylalanine. Clin. Sci. 77: 195-203.
36. Murphy, P. M., T. Ozcelik, R. T. Kenney, H. L. Tiffany, D. McDermott, and U. Francke. 1992. A structural homologue of the N-formyl peptide receptor: characterization and chromosome mapping of a peptide chemoattractant receptor family. J. Biol. Chem. 267: 7637-7643.
37. Browning, D. D., Z. K. Pan, E. R. Prossnitz, and R. D. Ye. 1997. Cell type- and developmental stage-specific activation of NF-κB by fMet-Leu-Phe in myeloid cells. J. Biol. Chem. 272: 7995-8001.
38. Gao, J. L., E. J. Lee, and P. M. Murphy. 1999. Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor. J. Exp. Med. 189: 657-662.
39. Deng, X., H. Ueda, S. B. Su, W. Gong, N. M. Dunlop, J. L. Gao, P. M. Murphy, and J. M. Wang. 1999. A synthetic peptide derived from human immunodeficiency virus type 1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R. Blood 94: 1165-1173.
40. Li, B. Q., M. A. Wetzel, J. A. Mikovits, E. E. Henderson, T. J. Rogers, W. Gong, Y. Le, F. W. Ruscetti, and J. M. Wang. 2001. The synthetic peptide WKYMVm attenuates the function of the chemokine receptors CCR5 and CXCR4 through activation of formyl peptide receptor-like 1. Blood 97: 2941-2947.
41. Betten, A., J. Bylund, T. Cristophe, F. Boulay, A. Romero, K. Hellstrand, and C. Dahlgren. 2001. A proinflammatory peptide from Helicobacter pylori activates monocytes to induce lymphocyte dysfunction and apoptosis. J. Clin. Invest. 108: 1221-1228.
42. De, Y., Q. Chen, A. P. Schmidt, G. M. Anderson, J. M. Wang, J. Wooters, J. J. Oppenheim, and O. Chertov. 2000. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192: 1069-1074.
43. Nagaoka, I., H. Tamura, and M. Hirata. 2006. An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7. J. Immunol. 176: 3044-3052.
44. Boman, H. G. 2003. Antibacterial peptides: basic facts and emerging concepts. J. Intern. Med. 254: 197-215.
45. Sieprawska-Lupa, M., P. Mydel, K. Krawczyk, K. Wojcik, M. Puklo, B. Lupa, P. Suder, J. Silberring, M. Reed, J. Pohl, et al. 2004. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob. Agents Chemother. 48: 4673-4679.
46. Fedtke, I., F. Gotz, and A. Peschel. 2004. Bacterial evasion of innate host defenses - the Staphylococcus aureus lesson. Int. J. Med. Microbiol. 294: 189-194.
47. Elagoz, A., D. Henderson, P. S. Babu, S. Salter, C. Grahames, L. Bowers, M. O. Roy, P. Laplante, E. Grazzini, S. Ahmad, and P. M. Lembo. 2004. A truncated form of CKβ8-1 is a potent agonist for human formyl peptide-receptor-like 1 receptor. Br. J. Pharmacol. 141: 37-46.
48. Bae, Y. S., J. C. Park, R. He, R. D. Ye, J. Y. Kwak, P. G. Suh, and R. S. Ho. 2003. Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils. Mol. Pharmacol. 64: 721-730.
49. Maddox, J. F., M. Hachicha, T. Takano, N. A. Petasis, V. V. Fokin, and C. N. Serhan. 1997. Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor. J. Biol. Chem. 272: 6972-6978.
50. Le, Y., R. D. Ye, W. Gong, J. Li, P. Iribarren, and J. M. Wang. 2005. Identification of functional domains in the formyl peptide receptor-like 1 for agonist-induced cell chemotaxis. FEBS J. 272: 769-778.
51. Yazawa, H., Z. X. Yu, Takeda, Y. Le, W. Gong, V. J. Ferrans, J. J. Oppenheim, C. C. Li, and J. M. Wang. 2001. β-Amyloid peptide (Aβ42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages. FASEB J. 15: 2454-2462.
52. Ying, G., P. Iribarren, Y. Zhou, W. Gong, N. Zhang, Z. X. Yu, Y. Le, Y. Cui, and J. M. Wang. 2004. Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor. J. Immunol. 172: 7078-7085.
53. Verdier, Y., and B. Penke. 2004. Binding sites of amyloid β-peptide in cell plasma membrane and implications for Alzheimer's disease. Curr. Protein Pept. Sci. 5: 19-31.
54. Su, S. B., J. Gao, W. Gong, N. M. Dunlop, P. M. Murphy, J. J. Oppenheim, and J. M. Wang. 1999. T21/DP107, a synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors. J. Immunol. 162: 5924-5930.
55. Robertson, M. J. 2002. Role of chemokines in the biology of natural killer cells. J. Leukocyte Biol. 71: 173-183.
56. Maghazachi, A. A. 2003. G protein-coupled receptors in natural killer cells. J. Leukocyte Biol. 74: 16-24.
57. Serhan, C. N. 1991. Lipoxins: eicosanoids carrying intra- and intercellular messages. J. Bioenerg. Biomembr. 23: 105-122.